Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 10, 2013, Pages 2201-2211

  Jellinghaus, Stefanie ^a   Poitz, David M ^a   Ende, Georg ^a   Augstein, Antje ^a   Weinert, Sönke ^a,c   Stütz, Beryl ^a   Braun Dullaeus, Rüdiger C ^a   Pasquale, Elena B ^b   Strasser, Ruth H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b BURNHAM INSTITUTE   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Adhesion; Atherosclerosis; Endothelium; Ephrin; Monocytes

Indexed keywords

EPHRIN A1; EPHRIN RECEPTOR A4; RHO FACTOR;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL COMMUNICATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADHESION; ATHEROSCLEROSIS; ENDOTHELIUM; EPHRIN; MONOCYTES;

ATHEROSCLEROSIS; BLOTTING, WESTERN; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EPHRIN-A1; EPHRIN-A4; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84879391391     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.05.017     Document Type: Article

References (39)

1. Murray C.J., Lopez A.D., Black R., Mathers C.D., Shibuya K., Ezzati M., Salomon J.A., Michaud C.M., Walker N., Vos T. Global burden of disease 2005: call for collaborators. Lancet 2007, 370:109-110.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 1999, 138:S419-S420.
4. Carpen O., Pallai P., Staunton D.E., Springer T.A. Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J. Cell Biol. 1992, 118:1223-1234.
5. Millan J., Hewlett L., Glyn M., Toomre D., Clark P., Ridley A.J. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat. Cell Biol. 2006, 8:113-123.
6. van Buul J.D., van R.J., van Alphen F.P., Hoogenboezem M., Tol S., Hoeben K.A., van M.J., Mul E.P., Hordijk P.L. Inside-out regulation of ICAM-1 dynamics in TNF-alpha-activated endothelium. PLoS One 2010, 5:e11336.
7. Pavalko F.M., Otey C.A. Role of adhesion molecule cytoplasmic domains in mediating interactions with the cytoskeleton. Proc. Soc. Exp. Biol. Med. 1994, 205:282-293.
8. Yoshida M., Westlin W.F., Wang N., Ingber D.E., Rosenzweig A., Resnick N., Gimbrone M.A. Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton. J. Cell Biol. 1996, 133:445-455.
9. Dawes A.T., Edelstein-Keshet L. Phosphoinositides and Rho proteins spatially regulate actin polymerization to initiate and maintain directed movement in a one-dimensional model of a motile cell. Biophys. J. 2007, 92:744-768.
10. Machesky L.M., Hall A. Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J. Cell Biol. 1997, 138:913-926.
11. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992, 70:389-399.
12. Wojciak-Stothard B., Williams L., Ridley A.J. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. J. Cell Biol. 1999, 145:1293-1307.
13. Pasquale E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 2010, 10:165-180.
14. Noren N.K., Pasquale E.B. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell. Signal. 2004, 16:655-666.
15. Pasquale E.B. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev. Mol. Cell Biol. 2005, 6:462-475.
16. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133:38-52.
17. Frisen J., Holmberg J., Barbacid M. Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J. 1999, 18:5159-5165.
18. Zhang J., Hughes S. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J. Pathol. 2006, 208:453-461.
19. Pfaff D., Heroult M., Riedel M., Reiss Y., Kirmse R., Ludwig T., Korff T., Hecker M., Augustin H.G. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J. Cell Sci. 2008, 121:3842-3850.
20. Zamora D.O., Babra B., Pan Y., Planck S.R., Rosenbaum J.T. Human leukocytes express ephrinB2 which activates microvascular endothelial cells. Cell. Immunol. 2006, 242:99-109.
21. Chan B., Sukhatme V.P. Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro. Thromb. Res. 2009, 123:745-752.
22. Braun J., Hoffmann S.C., Feldner A., Ludwig T., Henning R., Hecker M., Korff T. Endothelial cell ephrinB2-dependent activation of monocytes in arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:297-305.
23. Sakamoto A., Ishibashi-Ueda H., Sugamoto Y., Higashikata T., Miyamoto S., Kawashiri M.A., Yagi K., Konno T., Hayashi K., Fujino N., Ino H., Takeda Y., Yamagishi M. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. Clin. Sci. (Lond). 2008, 114:643-650.
24. Funk S.D., Yurdagul A., Albert P., Traylor J.G., Jin L., Chen J., Orr A.W. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:686-695.
25. Sakamoto A., Sugamoto Y., Tokunaga Y., Yoshimuta T., Hayashi K., Konno T., Kawashiri M.A., Takeda Y., Yamagishi M. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells. J. Int. Med. Res. 2011, 39:522-527.
26. Poitz D.M., Augstein A., Weinert S., Braun-Dullaeus R.C., Strasser R.H., Schmeisser A. OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway. Basic Res. Cardiol. 2011, 106:761-772.
27. Augstein A., Poitz D.M., Braun-Dullaeus R.C., Strasser R.H., Schmeisser A. Cell-specific and hypoxia-dependent regulation of human HIF-3alpha: inhibition of the expression of HIF target genes in vascular cells. Cell Mol. Life Sci. 2010, 68:2627-2642.
28. Schmeisser A., Christoph M., Augstein A., Marquetant R., Kasper M., Braun-Dullaeus R.C., Strasser R.H. Apoptosis of human macrophages by Flt-4 signaling: implications for atherosclerotic plaque pathology. Cardiovasc. Res. 2006, 71:774-784.
29. Ohta H., Wada H., Niwa T., Kirii H., Iwamoto N., Fujii H., Saito K., Sekikawa K., Seishima M. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005, 180:11-17.
30. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
31. Carlos T.M., Schwartz B.R., Kovach N.L., Yee E., Rosa M., Osborn L., Chi-Rosso G., Newman B., Lobb R. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990, 76:965-970.
32. Pober J.S., Lapierre L.A., Stolpen A.H., Brock T.A., Springer T.A., Fiers W., Bevilacqua M.P., Mendrick D.L., Gimbrone M.A. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 1987, 138:3319-3324.
33. Ishizaki T., Naito M., Fujisawa K., Maekawa M., Watanabe N., Saito Y., Narumiya S. p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett. 1997, 404:118-124.
34. Riento K., Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 2003, 4:446-456.
35. Binns K.L., Taylor P.P., Sicheri F., Pawson T., Holland S.J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 2000, 20:4791-4805.
36. Sahin M., Greer P.L., Lin M.Z., Poucher H., Eberhart J., Schmidt S., Wright T.M., Shamah S.M., O'connell S., Cowan C.W., Hu L., Goldberg J.L., Debant A., Corfas G., Krull C.E., Greenberg M.E. Eph-dependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse. Neuron 2005, 46:191-204.
37. Shamah S.M., Lin M.Z., Goldberg J.L., Estrach S., Sahin M., Hu L., Bazalakova M., Neve R.L., Corfas G., Debant A., Greenberg M.E. EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 2001, 105:233-244.
38. Yamashita T., Ohneda K., Nagano M., Miyoshi C., Kaneko N., Miwa Y., Yamamoto M., Ohneda O., Fujii-Kuriyama Y. Hypoxia-inducible transcription factor-2alpha in endothelial cells regulates tumor neovascularization through activation of ephrin A1. J. Biol. Chem. 2008, 283:18926-18936.
39. Taylor K.E., Glagov S., Zarins C.K. Preservation and structural adaptation of endothelium over experimental foam cell lesions. Quantitative ultrastructural study. Arteriosclerosis 1989, 9:881-894.